MEG8 and non-small cell lung carcinoma: It showed that the expression levels of MEG8 were significantly elevated in NSCLC patient tissues (n = 37) compared to that in the adjacent normal tissues (n = 37) (P < 0.05) (Fig. 1a), implying that MEG8 is associated with the clinical development of NSCLC.